High-Dose Platinum versus Standard Dose in Advanced Ovarian Carcinoma: A Randomized Trial from the Gynecologic Cooperative Group of the French Comprehensive Cancer Centers (FNCLCC)

By Joly F.   Heron J.F.   Kerbrat P.   Chauvergne J.   Rios M.   Mayer F.   Chinet-Charrot P.   Goupil A.   Lebrun-Jezekova D.   Vennin D.   Lhomme C.   Mace-Lesec'h J.   Crouet H.   for the Gynecologic Cooperative Group FNCLCC  

Gynecologic Oncology, Vol. 78, Iss. 3, 2000-09 ,pp. : 361-368

Elsevier

Access to resources Recommend Favorite

New Options in Direct Analysis of Dose-response Data

By Bentzen S.M.   Thames H.D.   Tucker S.L.   Smith C.  

International Journal of Radiation Biology, Vol. 57, Iss. 1, 1990-01 ,pp. : 221-225

Informa Healthcare

Access to resources Recommend Favorite

Chemotherapy in Metastatic Urothelial Cancer: Current and Future Treatment Options

By de Wit R.  

American Journal of Cancer, Vol. 1, Iss. 1, 2002-01 ,pp. : 23-31

Adis International

Access to resources Recommend Favorite

Polyadenylic–Polyuridylic Acid Plus Locoregional Radiotherapy Versus Chemotherapy with CMF in Operable Breast Cancer: a 14 Year Follow-up Analysis of a Randomized Trial of the Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC)

By Laplanche A.  

Breast Cancer Research and Treatment, Vol. 64, Iss. 2, 2000-11 ,pp. : 189-191

Springer Publishing Company

Access to resources Recommend Favorite

Cell proliferation as a predictor of response to chemotherapy in metastatic breast cancer: A prospective study

By Amadori D.  

Breast Cancer Research and Treatment, Vol. 43, Iss. 1, 1997-03 ,pp. : 7-14

Springer Publishing Company

Access to resources Recommend Favorite